Skip to main content
Top
Published in:

Open Access 01-12-2024 | Case report

Late relapse of anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis: a case report

Authors: Hamidreza Amiri, Mehdi Karimi, Fakhreddin Shariatmadari

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Anti-N-methyl-d-aspartate receptor encephalitis is a sporadic autoimmune disorder of the brain that presents in a variety of neuropsychiatric manifestations, including seizures, psychosis, and alterations in behavior. N-methyl-d-aspartate receptor is primarily seen in young females. Although this disease can be treated, it can relapse in rare cases. Relapsing typically occurs within the early years following the initial episode and is exceedingly rare after 5 years.

Case presentation

In this case study, we report on a 16-year-old Iranian female experiencing a relapse of anti-N-methyl-d-aspartate receptor encephalitis 8 years after her initial diagnosis. She was admitted to the hospital with dysphasia (a speech disorder) and dyslexia (reading and writing impairment). A thorough clinical evaluation revealed the presence of anti-glutamate receptor type N-methyl-d-aspartate receptor antibodies in her serum and cerebrospinal fluid, confirming the diagnosis. Following treatment with immunotherapy and plasmapheresis, she made a complete recovery.

Conclusion

This case of relapsing anti-N-methyl-d-aspartate receptor encephalitis, occurring more than 5 years after the initial episode, is exceptionally rare. This late relapse underscores the importance of long-term follow-up for patients with this condition.
Literature
1.
go back to reference Wang H, Xiao Z. Current progress on assessing the prognosis for anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. Biomed Res Int. 2020;2020:7506590.PubMedPubMedCentral Wang H, Xiao Z. Current progress on assessing the prognosis for anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. Biomed Res Int. 2020;2020:7506590.PubMedPubMedCentral
2.
go back to reference Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57.CrossRefPubMed Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57.CrossRefPubMed
3.
go back to reference Samanta D, Lui F. Anti-NMDAR encephalitis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright© 2024, StatPearls Publishing LLC; 2024. Samanta D, Lui F. Anti-NMDAR encephalitis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright© 2024, StatPearls Publishing LLC; 2024.
5.
go back to reference Hiesgen J, Schutte C. Autoimmune encephalitis: part 1 (epidemiology, pathophysiology and clinical spectrum). S Afr Med J. 2023;113(3):116–21.CrossRefPubMed Hiesgen J, Schutte C. Autoimmune encephalitis: part 1 (epidemiology, pathophysiology and clinical spectrum). S Afr Med J. 2023;113(3):116–21.CrossRefPubMed
7.
go back to reference Han Y, Gong S, Wan Y, Fu X, He E, Liu M, et al. Case report: anti-NMDA receptor encephalitis manifesting as rapid weight loss and abnormal movement disorders with alternating unilateral ptosis and contralateral limb tremor. Front Immunol. 2022;13: 971514.CrossRefPubMedPubMedCentral Han Y, Gong S, Wan Y, Fu X, He E, Liu M, et al. Case report: anti-NMDA receptor encephalitis manifesting as rapid weight loss and abnormal movement disorders with alternating unilateral ptosis and contralateral limb tremor. Front Immunol. 2022;13: 971514.CrossRefPubMedPubMedCentral
8.
go back to reference Feng J, Yang M, Cui D, Huang Z, Ji T, Lian Y. Recurrence of anti-N-methyl-d-aspartate receptor encephalitis: a cohort study in central China. Front Neurol. 2022;13: 832634.CrossRefPubMedPubMedCentral Feng J, Yang M, Cui D, Huang Z, Ji T, Lian Y. Recurrence of anti-N-methyl-d-aspartate receptor encephalitis: a cohort study in central China. Front Neurol. 2022;13: 832634.CrossRefPubMedPubMedCentral
9.
go back to reference Gong X, Chen C, Liu X, Lin J, Li A, Guo K, et al. Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in Western China. Neurol-Neuroimmunol Neuroinflamm. 2021;8(2). Gong X, Chen C, Liu X, Lin J, Li A, Guo K, et al. Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in Western China. Neurol-Neuroimmunol Neuroinflamm. 2021;8(2).
10.
go back to reference Chiang S, Garg T, Hu A, Amin H, Davalos-Balderas A, Alfradique-Dunham I, et al. Pearls & Oy-sters: relapse of anti-NMDA receptor encephalitis after prior first-and second-line immunotherapy. Neurology. 2018;90(20):936–9.CrossRefPubMed Chiang S, Garg T, Hu A, Amin H, Davalos-Balderas A, Alfradique-Dunham I, et al. Pearls & Oy-sters: relapse of anti-NMDA receptor encephalitis after prior first-and second-line immunotherapy. Neurology. 2018;90(20):936–9.CrossRefPubMed
11.
go back to reference Ma Y, Wang J, Guo S, Meng Z, Ren Y, Xie Y, et al. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: a systematic review and meta-analysis. Front Immunol. 2022;13:1064007.CrossRefPubMed Ma Y, Wang J, Guo S, Meng Z, Ren Y, Xie Y, et al. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: a systematic review and meta-analysis. Front Immunol. 2022;13:1064007.CrossRefPubMed
12.
go back to reference He S, Sun C, Zhu Q, Li L, Huang J, Wu G, et al. A juvenile mouse model of anti-N-methyl-d-aspartate receptor encephalitis by active immunization. Front Mol Neurosci. 2023;16:1211119.CrossRefPubMedPubMedCentral He S, Sun C, Zhu Q, Li L, Huang J, Wu G, et al. A juvenile mouse model of anti-N-methyl-d-aspartate receptor encephalitis by active immunization. Front Mol Neurosci. 2023;16:1211119.CrossRefPubMedPubMedCentral
13.
go back to reference Potorac A, Varlas VN, Borș RG, Baroș A, Cirstoiu M. The management and diagnosis of anti-NMDA receptor autoimmune encephalitis in pregnant women: a case report and literature review. Medicina. 2023;59(12):2110.CrossRefPubMedPubMedCentral Potorac A, Varlas VN, Borș RG, Baroș A, Cirstoiu M. The management and diagnosis of anti-NMDA receptor autoimmune encephalitis in pregnant women: a case report and literature review. Medicina. 2023;59(12):2110.CrossRefPubMedPubMedCentral
14.
go back to reference Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015;39(1):19–23.CrossRefPubMedPubMedCentral Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015;39(1):19–23.CrossRefPubMedPubMedCentral
15.
go back to reference Nishida H, Kohyama K, Kumada S, Takanashi JI, Okumura A, Horino A, et al. Evaluation of the diagnostic criteria for anti-NMDA receptor encephalitis in Japanese children. Neurology. 2021;96(16):e2070–7.CrossRefPubMed Nishida H, Kohyama K, Kumada S, Takanashi JI, Okumura A, Horino A, et al. Evaluation of the diagnostic criteria for anti-NMDA receptor encephalitis in Japanese children. Neurology. 2021;96(16):e2070–7.CrossRefPubMed
17.
go back to reference Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2018;11:1756285617722347.CrossRefPubMed Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2018;11:1756285617722347.CrossRefPubMed
18.
go back to reference Halliday A, Duncan A, Cheung M, Boston RC, Apiwattanakul M, Camacho X, et al. Second-line immunotherapy and functional outcomes in autoimmune encephalitis: a systematic review and individual patient data meta-analysis. Epilepsia. 2022;63(9):2214–24.CrossRefPubMedPubMedCentral Halliday A, Duncan A, Cheung M, Boston RC, Apiwattanakul M, Camacho X, et al. Second-line immunotherapy and functional outcomes in autoimmune encephalitis: a systematic review and individual patient data meta-analysis. Epilepsia. 2022;63(9):2214–24.CrossRefPubMedPubMedCentral
19.
go back to reference Koparal B, Çiçek S, Taner ME, Kuruoğlu A. A rapidly progressive case of anti-NMDAR encephalitis with primary psychiatric symptoms. Psychiatr Danub. 2021;33(2):177–9.CrossRefPubMed Koparal B, Çiçek S, Taner ME, Kuruoğlu A. A rapidly progressive case of anti-NMDAR encephalitis with primary psychiatric symptoms. Psychiatr Danub. 2021;33(2):177–9.CrossRefPubMed
20.
go back to reference Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J, et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord. 2021;47: 102604.CrossRefPubMed Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J, et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord. 2021;47: 102604.CrossRefPubMed
21.
go back to reference Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.CrossRefPubMedPubMedCentral Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.CrossRefPubMedPubMedCentral
22.
go back to reference Zhong R, Chen Q, Zhang X, Zhang H, Lin W. Relapses of anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis: a retrospective cohort study. Front Immunol. 2022;13: 918396.CrossRefPubMedPubMedCentral Zhong R, Chen Q, Zhang X, Zhang H, Lin W. Relapses of anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis: a retrospective cohort study. Front Immunol. 2022;13: 918396.CrossRefPubMedPubMedCentral
23.
go back to reference Gabilondo I, Saiz A, Galán L, González V, Jadraque R, Sabater L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011;77(10):996–9.CrossRefPubMed Gabilondo I, Saiz A, Galán L, González V, Jadraque R, Sabater L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011;77(10):996–9.CrossRefPubMed
24.
go back to reference Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167–77.CrossRefPubMed Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167–77.CrossRefPubMed
25.
go back to reference Zeng W, Cao L, Zheng J, Yu L. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-d-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study. Neurol Sci. 2021;42:199–207.CrossRefPubMed Zeng W, Cao L, Zheng J, Yu L. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-d-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study. Neurol Sci. 2021;42:199–207.CrossRefPubMed
26.
27.
go back to reference Kayal AK, Das M, Bhowmick S, Synmon B. Relapsing anti-NMDAR encephalitis after a gap of eight years in a girl from North-East India. Ann Indian Acad Neurol. 2014;17(3):349–51.CrossRefPubMedPubMedCentral Kayal AK, Das M, Bhowmick S, Synmon B. Relapsing anti-NMDAR encephalitis after a gap of eight years in a girl from North-East India. Ann Indian Acad Neurol. 2014;17(3):349–51.CrossRefPubMedPubMedCentral
28.
go back to reference Yamada N, Kuki I, Hattori T, Yamamoto N, Nagase S, Nukui M, et al. Late relapse of anti-N-methyl-d-aspartate receptor encephalitis with amusia and transiently reduced uptake in (123)I-iomazenil single-photon emission computed tomography. Brain Dev. 2022;44(8):558–61.CrossRefPubMed Yamada N, Kuki I, Hattori T, Yamamoto N, Nagase S, Nukui M, et al. Late relapse of anti-N-methyl-d-aspartate receptor encephalitis with amusia and transiently reduced uptake in (123)I-iomazenil single-photon emission computed tomography. Brain Dev. 2022;44(8):558–61.CrossRefPubMed
29.
go back to reference Ramanathan S, Mohammad SS, Brilot F, Dale RC. Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci. 2014;21(5):722–30.CrossRefPubMed Ramanathan S, Mohammad SS, Brilot F, Dale RC. Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci. 2014;21(5):722–30.CrossRefPubMed
Metadata
Title
Late relapse of anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis: a case report
Authors
Hamidreza Amiri
Mehdi Karimi
Fakhreddin Shariatmadari
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04886-5